SEAL @214 (99.9%) on 22-feb-2011 [ 12345678910 ] using warner_chilcott
CPL @1095 (94.5%) on 17-jan-2018 [ "_ develops pharmaceuticals" "tablets are manufactured by _" "_ is a specialty pharmaceutical company" "flows generated by _" "_ 's citizen petition" "future cash flows generated by _" "educational grants from _" "_ 's DCF Analysis" "Helpful Information for _" "_ 's comparative multiple analysis" "_ 's WACC calculation" "_ 's Actonel" "pharmaceutical companies such as _" "pharmaceutical sales representative for _" "medication is manufactured by _" "_ submitted an NDA" "similar settlement with _" "unrestricted educational grants from _" "_ 's equity research report" "AB-rated generic equivalent of _" "_ 's DCF analysis" ] using warner_chilcott
relations
NELL has only weak evidence for items listed in grey